The Acute Coronary Syndrome Research Group belongs among pioneers of primary percutaneous coronary intervention program in the Czech Republic and among one of the largest centers. The main activity of the ACS Research Group is interventional cardiology, treatment of coronary artery disease by percutaneous coronary interventions and treatment of acute coronary syndromes. The main research is focused on a new stent and scaffolds development, treatment of ST-Elevation Myocardial Infarction (STEMI) patients with multivessel disease, antiaggregation therapy after acute coronary syndromes, Tako-tsubo Cardiomyopathy, new imaging methods of coronary arteries and atherosclerotic plaque progression.
Novel Ferromagnetic Bare Metal Stent Capable of Capturing and Retaining Endothelial Cells – New type of stent for Rapid healing of vascular system reducing complications associated with stent thrombosis, restenosis, and bleeding related to antiplatelet drugs.
Novel Ferromagnetic Stent Graft – New type ofstent graft with small diameter (3 mm) - magnetic stent graft of rapid endothelialization represents a new therapeutic approach in peripheral and coronary arteries, thereby reducing the need for prolonged anticoagulation and antiplatelet therapy.